Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs developed initially for treatment of type 2 diabetes (T2D) and then obesity, by mimicking the incretin effect which includes glucose-dependent increased insulin secretion and improved glycaemic control, and inducing weight loss in a dose-dependent manner [1]
This amount of weight loss brings comprehensive health benefits ranging from improved cardiovascular health and lower blood pressure, enhanced insulin sensitivity and better glucose control, improvements to the GI system, and overall positive impacts on self esteem, depression, anxiety, sleep, and cognitive function
The researchers also noted limitations in their approach, including reliance on theoretical meal plans and single-day analysis, which may not represent long-term dietary patterns
GLP-1 provides the appetite suppression foundation, but GIP fundamentally changes how the body responds metabolically in ways that dramatically amplify weight loss beyond what GLP-1 alone achieves
Yes, these medications do more than just reduce food intake
Unlike oral supplements that must pass through your digestive system, IV therapy provides immediate benefits by delivering nutrients directly to your cells